Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · John B. Sanfilippo & Son (JBSS)

John B. Sanfilippo Q2 diluted EPS rises 31.9% to $1.53 on 4.6% sales gain

Positive Impact 3 of 5 earnings Written later

John B. Sanfilippo & Son reported fiscal 2026 second-quarter results for the period ended December 25, 2025. Net sales rose 4.6% to $314.8 million and diluted earnings per share rose 31.9% to $1.53, although sales volume fell 9.7%, with higher selling prices driving the revenue gain. Shareholders received higher profit per share, while the company said it has navigated headwinds from shifting consumer behavior and elevated retail selling prices.

Key points

  • Net sales rose $13.7 million, or 4.6%, to $314.8 million, driven by a 15.8% increase in weighted average selling price per pound
  • Diluted EPS was $1.53 versus $1.16 a year earlier; six-month diluted EPS was $3.12, up 44.4%
  • Sales volume fell 9.7% to 87.0 million pounds; gross profit margin rose to 18.8% of net sales from 17.4%
  • A special dividend of $1.00 per share was distributed at the start of the third quarter; an investor call is set for January 30, 2026

The filing

CompanyJohn B. Sanfilippo & Son (JBSS)
Form8-K, current report
Filed with the SECJan 29, 2026, 4:16 PM ET
Accession number0001193125-26-029383

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.